Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1394studies shown
Showing 751-775 of 1,394
WithdrawnNCT04430959

Candesartan as an Adjunctive Treatment for Depression in bipolarity

This study exists to better understand the safety of blood tests and biological markers and how manageable it feels in practice. Researchers are trying to understand how people respond to blood tests and biological markers in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Depression
CompletedNCT02845440

Integrated Smoking Cessation Treatment for Smokers With Serious Mental Illness

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand how people respond to smoking support or smoking-related treatment in practice and what may need to be adjusted.

DepressionOtherOver 18 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
Depression
CompletedNCT04417049

Treatment of Depression in bipolarity With Pentoxifylline

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

DepressionOtherFrom 18 Years to 65 Years
Countries
Canada
Sponsor
University Health Network, Toronto
Condition
Depression
CompletedNCT01986101

A Phase III Study of SM-13496 in Patients With Bipolar I Depression.

This study exists to compare options and see whether the medication SM-13496 offers something meaningfully different. Researchers are trying to understand how people respond to the medication SM-13496 in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 74 Years
Countries
Japan, Lithuania, Malaysia, Philippines, Russian Federation, Slovakia, Taiwan, Ukraine
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Depression
CompletedNCT01986114

A Long-Term Study of SM-13496 in Patients With Bipolarity I.

This study exists to understand how the medication SM-13496 holds up over time after the earliest research stage. Researchers are trying to understand how people respond to the medication SM-13496 in practice and what may need to be adjusted.

BipolarityOtherFrom 18 Years to 74 Years
Countries
Japan, Lithuania, Malaysia, Philippines, Russian Federation, Slovakia, Taiwan, Ukraine
Sponsor
Sumitomo Pharma Co., Ltd.
Condition
Bipolarity
CompletedNCT03630822

Multicenter, Randomized, Comparative and Prospective Study Evaluating the Impact on the Care Path of an Editorial Program Accompanied by Advance Directives in Psychiatry (DAP) for People Suffering From Schizophrenia, Bipolarity I or Schizoaffective Disorder

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.

SchizophreniaOtherOver 18 Years
Countries
France
Sponsor
Assistance Publique Hopitaux De Marseille
Condition
Schizophrenia
CompletedNCT00484471

ABLE: Abilify in Bipolarity for Long-term Effectiveness

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.

BipolarityOtherFrom 18 Years to 65 Years
Countries
China, Philippines, Taiwan, Thailand
Sponsor
Korea Otsuka International Asia Arab
Condition
Bipolarity
CompletedNCT03156504

The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.

This study exists to see whether the medication Ketamine can play a useful role in care. Researchers are trying to understand whether the medication Ketamine can better support energy, concentration, and everyday functioning.

DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Depression
CompletedNCT03959735

High Intensity Interval Training in Severe Mental Illness

This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

DepressionOtherOver 18 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Depression
TerminatedNCT02707276

LFMS: Initial Trial in Geriatric Depression in bipolarity

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

DepressionOtherFrom 55 Years to 85 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Depression
CompletedNCT03408873

CAE Plus LAI in Individuals With Bipolarity at Risk for Treatment Non-adherence (BD-CAEL)

This study exists to see whether psychoeducation, a guided learning and support program, can play a useful role in care. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can work better when mental health difficulties overlap with substance use.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
Martha Sajatovic
Condition
Bipolarity
CompletedNCT03386851

Abilify Maintena PMS in Schizophrenia Patients or Bipolarity type I

This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

SchizophreniaOtherOver 19 Years
Countries
South Korea
Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
Condition
Schizophrenia
TerminatedNCT03206463

Cognitive and Psychophysiological Effects of Delta-9-Tetrahydrocannabinol in Bipolarity

This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

BipolarityOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
Yale University
Condition
Bipolarity
CompletedNCT04222816

Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolarity

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 60 Years
Countries
India
Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Condition
Bipolarity
TerminatedNCT02726659

Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand how people respond to this type of care in practice and what may need to be adjusted.

DepressionOtherFrom 18 Years to 45 Years
Countries
Canada
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Condition
Depression
CompletedNCT04098497

Modeling Mood Course to Detect Markers for Effective Adaptive Interventions- Aim 3

This study exists to understand how acceptance and commitment therapy, a talking treatment, holds up over time after the earliest research stage. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can make support easier to access outside standard clinic visits.

BipolarityOtherOver 18 Years
Countries
United States
Sponsor
University of Wisconsin, Madison
Condition
Bipolarity
CompletedNCT01503489

Risk Factors for AD-Associated Switch to Mania

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

BipolarityOtherFrom 18 Years to 80 Years
Countries
Spain
Sponsor
Hospital Clinic of Barcelona
Condition
Bipolarity
CompletedNCT04095559

Characterization of Left Atrial Substrate by Comparison of Bipolar Voltage Maps With Standard Focal 4.5 mm Tip Electrode, 1 mm Ring Electrode, and Microelectrode Catheters Using InTEllaMap Orion and IntellaNav MIFI O

This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

BipolarityOtherOver 18 Years
Countries
Switzerland
Sponsor
University Hospital, Basel, Switzerland
Condition
Bipolarity
CompletedNCT02184767

Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication

This study exists to explore whether a medication treatment could improve care and understanding. For people living with Bipolarity, that matters because care needs to work in daily life, not just in theory.

BipolarityOtherFrom 10 Years to 17 Years
Countries
United States
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Bipolarity